Cadrenal Therapeutics, Inc Common Stock

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$0
$0
$0
$2
Gross Profit
2
EBITDA
-2,459
-2,392
-1,662
-1,143
EBIT
-2,460
-2,392
-1,663
-1,144
Net Income
-2,407
-2,392
-1,663
-1,144
Net Change In Cash
0
0
0
2
Free Cash Flow
-2,201
-1,529
-1,836
-697
Cash
4,363
5,037
6,566
8,402
Basic Shares
1,104
1,067
1,070
868

Annual Financials

Values in thousands 2023-12-31
Revenue
$0
Gross Profit
-1
EBITDA
-8,338
EBIT
-8,339
Net Income
-8,357
Net Change In Cash
0
Free Cash Flow
-3,533
Cash
8,402
Basic Shares
13,491

Earnings Calls

Quarter EPS
2024-09-30
-$2.18
2024-06-30
-$2.25
2024-03-31
-$0.10
2023-12-31
-$0.05